You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Allergies and anaphylaxis

Drug allergy

  • Quality standard
  • Reference number: QS97
  • Published:  30 July 2015
  • Quality standard
  • Tools and resources
  • History
Download (PDF)
  • Overview
  • Quality statements
  • Quality statement 1: Documentation using the structured assessment guide
  • Quality statement 2: Advice about carrying personal structured drug information
  • Quality statement 3: Referral to specialist drug allergy services
  • Quality statement 4: Recording drug allergy status in electronic medical records
  • Quality statement 5: Updating information on drug allergy status
  • Quality statement 6 (developmental): Prescription information on drug avoidance
  • Update information
  • About this quality standard

Update information

Minor changes since publication

May 2026: Changes have been made to align this quality standard with the update to NICE's guideline on anaphylaxis: assessment and referral after emergency treatment. For quality statement 3 on referral to specialist drug allergy services, the term anaphylactic reaction has been changed to anaphylaxis in line with updates to the wording used in the guideline. The source guidance has also been updated for this quality statement.


Next page About this quality standard Previous page Quality statement 6 (developmental): Prescription information on drug avoidance
Back to top